Dexamethasone intravitreal implant for the treatment of macular oedema secondary to retinal vein occlusion

Macular oedema (retinal vein occlusion) - dexamethasone: review decision - January 2015 information

Macular oedema (retinal vein occlusion) - dexamethasone: appendix A

Macular oedema (retinal vein occlusion) - dexamethasone: appendix A (PDF 77 KB)

Macular oedema (retinal vein occlusion) - dexamethasone: review proposal November 2014 information

Macular oedema (retinal vein occlusion) - dexamethasone: Appendix B - proposal paper presented to the Institutes Guidance Executive

Macular oedema (retinal vein occlusion) - dexamethasone: Appendix B - proposal paper presented to the Institutes Guidance Executive (PDF 295 KB)

Macular oedema (retinal vein occlusion) - dexamethasone: Appendix A - provisional matrix of stakeholders

Macular oedema (retinal vein occlusion) - dexamethasone: equality impact assessment

Macular oedema (retinal vein occlusion) - dexamethasone: final appraisal determination information

Macular oedema (retinal vein occlusion) - dexamethasone: final appraisal determination document

Macular oedema (retinal vein occlusion) - dexamethasone: final appraisal determination document (PDF 248 KB)

Response to consultee, commentator and public comments on the Appraisal Consultation Document (ACD)

Response to consultee, commentator and public comments on the Appraisal Consultation Document (ACD) (PDF 179 KB)

Consultee and commentator comments on the ACD

Allergan cover letter

Allergan cover letter (PDF 193 KB)

Allergen response to ACD

Allergen response to ACD (PDF 460 KB)

Allergan additional analysis

Allergan additional analysis (PDF 855 KB)

Appendices to the additional analysis

Appendices to the additional analysis (PDF 736 KB)

RNIB ACD comments

RNIB ACD comments (PDF 57 KB)

RCO ACD comments

RCO ACD comments (PDF 103 KB)

RCN ACD comments

RCN ACD comments (PDF 51 KB)

NHS Waltham Forest ACD comments

NHS Waltham Forest ACD comments (PDF 288 KB)

Comments on the ACD received from the public through the NICE website

NHS Wirrall

NHS Wirrall (PDF 29 KB)

NHS Bradford and Airedale

NHS Bradford and Airedale (PDF 46 KB)

Additional ERG critique post ACD by Aberdeen HTA Group

Macular oedema (retinal vein occlusion) - dexamethasone: appraisal consultation

Macular oedema (retinal vein occlusion) - dexamethasone: appraisal consultation document information

Macular oedema (retinal vein occlusion) - dexamethasone: evaluation report

Macular oedema (retinal vein occlusion) - dexamethasone: pre-meeting briefing

Macular oedema (retinal vein occlusion) - dexamethasone: pre-meeting briefing (PDF 290 KB)

Macular oedema (retinal vein occlusion) - dexamethasone: final scope

Macular oedema (retinal vein occlusion) - dexamethasone: final scope (PDF 61 KB)

Macular oedema (retinal vein occlusion) - dexamethasone: final matrix

Macular oedema (retinal vein occlusion) - dexamethasone: final matrix (PDF 49 KB)

Macular oedema (retinal vein occlusion) - dexamethasone: manufacturer submissions

Macular oedema (retinal vein occlusion) - dexamethasone: submission from Allergan Pharmaceuticals

Macular oedema (retinal vein occlusion) - dexamethasone: submission from Allergan Pharmaceuticals (PDF 7.87 MB)

Macular oedema (retinal vein occlusion) - dexamethasone: submission from Allergan Pharmaceuticals - additional analyses

Macular oedema (retinal vein occlusion) - dexamethasone: submission from Allergan Pharmaceuticals - additional analyses (PDF 2.67 MB)

Macular oedema (retinal vein occlusion) - dexamethasone: clarification letters

Macular oedema (retinal vein occlusion) - dexamethasone: NICE request to the manufacturer for clarification on their submission

Macular oedema (retinal vein occlusion) - dexamethasone: NICE request to the manufacturer for clarification on their submission (PDF 135 KB)

Macular oedema (retinal vein occlusion) - dexamethasone: Manufacturer's response to NICE's request for clarification

Macular oedema (retinal vein occlusion) - dexamethasone: Manufacturer's response to NICE's request for clarification (PDF 871 KB)

Macular oedema (retinal vein occlusion) - dexamethasone: non-manufacturer submissions

Macular oedema (retinal vein occlusion) - dexamethasone: submission from Macular Disease Society and Royal National Institute of Blind People (RNIB) (joint submission)

Macular oedema (retinal vein occlusion) - dexamethasone: submission from Macular Disease Society and Royal National Institute of Blind People (RNIB) (joint submission) (PDF 60 KB)

Macular oedema (retinal vein occlusion) - dexamethasone: submission from Macular Disease Society and Royal National Institute of Blind People (RNIB) (joint submission) - case study A

Macular oedema (retinal vein occlusion) - dexamethasone: submission from Macular Disease Society and Royal National Institute of Blind People (RNIB) (joint submission) - case study A (PDF 8.6 KB)

Macular oedema (retinal vein occlusion) - dexamethasone: submission from Macular Disease Society and Royal National Institute of Blind People (RNIB) (joint submission) - case study B

Macular oedema (retinal vein occlusion) - dexamethasone: submission from Macular Disease Society and Royal National Institute of Blind People (RNIB) (joint submission) - case study B (PDF 36 KB)

Macular oedema (retinal vein occlusion) - dexamethasone: submission from Macular Disease Society and Royal National Institute of Blind People (RNIB) (joint submission) - case study C

Macular oedema (retinal vein occlusion) - dexamethasone: submission from Macular Disease Society and Royal National Institute of Blind People (RNIB) (joint submission) - case study C (PDF 8.7 KB)

Macular oedema (retinal vein occlusion) - dexamethasone: submission from Macular Disease Society and Royal National Institute of Blind People (RNIB) (joint submission) - case study D

Macular oedema (retinal vein occlusion) - dexamethasone: submission from Macular Disease Society and Royal National Institute of Blind People (RNIB) (joint submission) - case study D (PDF 11 KB)

Macular oedema (retinal vein occlusion) - dexamethasone: submission from Royal College of Nursing

Macular oedema (retinal vein occlusion) - dexamethasone: submission from Royal College of Nursing (PDF 61 KB)

Macular oedema (retinal vein occlusion) - dexamethasone: submission from Royal College of Ophthalmologists

Macular oedema (retinal vein occlusion) - dexamethasone: submission from Royal College of Ophthalmologists (PDF 119 KB)

Macular oedema (retinal vein occlusion) - dexamethasone: submission from Royal College of Ophthalmologists - Interim Guidelines for Management of Retinal Vein Occlusion

Macular oedema (retinal vein occlusion) - dexamethasone: submission from Royal College of Ophthalmologists - Interim Guidelines for Management of Retinal Vein Occlusion (PDF 287 KB)

Macular oedema (retinal vein occlusion) - dexamethasone: expert personal statements

Macular oedema (retinal vein occlusion) - dexamethasone: expert personal statement - McLaughlan

Macular oedema (retinal vein occlusion) - dexamethasone: expert personal statement - McLaughlan (PDF 17 KB)

Macular oedema (retinal vein occlusion) - dexamethasone: expert personal statement - Pearce

Macular oedema (retinal vein occlusion) - dexamethasone: expert personal statement - Pearce (PDF 18 KB)

Macular oedema (retinal vein occlusion) - dexamethasone: expert personal statement - Read

Macular oedema (retinal vein occlusion) - dexamethasone: expert personal statement - Read (PDF 20 KB)

Macular oedema (retinal vein occlusion) - dexamethasone: expert personal statement - Taylor

Macular oedema (retinal vein occlusion) - dexamethasone: expert personal statement - Taylor (PDF 11 KB)

Macular oedema (retinal vein occlusion) - dexamethasone: evidence review group report

Macular oedema (retinal vein occlusion) - dexamethasone: Evidence Review Group report

Macular oedema (retinal vein occlusion) - dexamethasone: Evidence Review Group report (PDF 1.47 MB)

Macular oedema (retinal vein occlusion) - dexamethasone: Evidence Review Group report - additional analyses

Macular oedema (retinal vein occlusion) - dexamethasone: Evidence Review Group report - additional analyses (PDF 158 KB)

Macular oedema (retinal vein occlusion) - dexamethasone: Evidence Review Group report - factual accuracy check

Macular oedema (retinal vein occlusion) - dexamethasone: final scope

Macular oedema (retinal vein occlusion) - dexamethasone: final matrix

Macular oedema (retinal vein occlusion) - dexamethasone: Institute's response to consultee and commentator comments on the draft scope

Macular oedema (retinal vein occlusion) - dexamethasone: Institute's response to consultee and commentator comments on the draft scope

Appendix B: draft scope for consultation (pre-referral) 

Appendix C: provisional matrix (pre-referral)